Skip to main content

Table 2 Baseline patients’ characteristics

From: Evaluation of long-term changes of aspartate—platelet ratio index, FIB4, and liver stiffness in chronic hepatitis C patients successfully treated by direct-acting antivirals

Age (years) 48 ±15
BMI 26 ±3.7
Female (%) 48
Male (%) 52
Diabetes (%) 14
Hypertension (%) 12
Other co-morbidities*(%) 11
HCV RNA quantitative* 2066.45±4000
ALT (IU/L) 53.5±40
AST (IU/L) 48±29
AFP (IU/L) 4.3±3.4
Albumin (g/dL) 4.1±0.5
Total bilirubin (mg/dL) 0.75±0.4
Indirect bilirubin (mg/dL) 0.48±0.4
WBCx103/mm3 7.1±2.2
Hb (g/dL) 13.5±1.8
Creatinine (mg/dL) 0.9±0.2
INR 1.1±0.1
Platelets×103/mm3 231.7±72
Fibrosis stage (F) by TE (%) F0 (23%)
F1 (26%)
F2 (14 %)
F3 (9%)
F4 (28%)
  1. *Ischemic heart diseases and bronchial asthma